9[1]Berman E,Mc Bride M.Comparative cellular pharmacology of dannorubicin and idarubicin in human multidrug-resistant leukemia cells[J].Blood 1992,79:3267-3273.
10[2]Rieffers J,Huguet F,Stoppa AM.A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myetogenous leukemia of the age group 55 to 75[J].Leukemia,1996,10:389-395.
